Found: 67
Select item for more details and to access through your institution.
Front‐line and second‐line treatment for mantle cell lymphoma in clinical practice: A multicenter retrospective analysis.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 2, p. 218, doi. 10.1111/ejh.14219
- By:
- Publication type:
- Article
Efficacy of conventional‐dose cytarabine, idarubicin and thioguanine versus intermediate‐dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long‐term results of the prospective randomized nationwide AML‐2003 study by the Finnish Leukemia Group
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 3, p. 257, doi. 10.1111/ejh.13805
- By:
- Publication type:
- Article
Febrile neutropenia in patients with acute myeloid leukemia: Outcome in relation to qSOFA score, C‐reactive protein, and blood culture findings.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 6, p. 731, doi. 10.1111/ejh.13500
- By:
- Publication type:
- Article
Interleukin‐1 receptor antagonist as a biomarker of sepsis in neutropenic haematological patients.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 5, p. 691, doi. 10.1111/ejh.13161
- By:
- Publication type:
- Article
Impact of the number of cryopreserved CD34<sup>+</sup> cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation: Experience from the GOA study.
- Published in:
- Journal of Clinical Apheresis, 2023, v. 38, n. 1, p. 33, doi. 10.1002/jca.22022
- By:
- Publication type:
- Article
A prospective comparison of pegfilgrastim and lipegfilgrastim combined with chemotherapy in the mobilization of CD34<sup>+</sup> cells in NHL patients.
- Published in:
- Journal of Clinical Apheresis, 2020, v. 35, n. 4, p. 255, doi. 10.1002/jca.21785
- By:
- Publication type:
- Article
Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOP.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-33230-3
- By:
- Publication type:
- Article
Promising treatment results with blood brain barrier disruption (BBBD) based immunochemotherapy combined with autologous stem cell transplantation (ASCT) in patients with primary central nervous system lymphoma (PCNSL).
- Published in:
- Journal of Neuro-Oncology, 2017, v. 131, n. 2, p. 293, doi. 10.1007/s11060-016-2293-8
- By:
- Publication type:
- Article
Pulsed dexamethasone for refractory idiopathic thrombocytopenic purpura.
- Published in:
- American Journal of Hematology, 1996, v. 53, n. 4, p. 281, doi. 10.1002/(SICI)1096-8652(199612)53:4<281::AID-AJH18>3.0.CO;2-F
- By:
- Publication type:
- Article
Gray platelet syndrome with splenomegaly and signs of extramedullary hematopoiesis: A case report with review of the literature.
- Published in:
- American Journal of Hematology, 1994, v. 46, n. 3, p. 218, doi. 10.1002/ajh.2830460311
- By:
- Publication type:
- Article
Jehovah's witnesses and acute leukemia.
- Published in:
- American Journal of Hematology, 1993, v. 43, n. 2, p. 158, doi. 10.1002/ajh.2830430225
- By:
- Publication type:
- Article
Loss of CD34<sup>+</sup> Cells and Effect of the Number of Viable Cryopreserved CD34<sup>+</sup> Cells in the Infused Blood Grafts on Hematologic Recovery, Progression-Free Survival and Overall Survival in NHL Patients After Autologous Stem Cell Transplantation
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 11, p. e428, doi. 10.1016/j.clml.2023.08.009
- By:
- Publication type:
- Article
A phase 2 study of carfilzomib plus elotuzumab plus dexamethasone for myeloma patients relapsed after 1-3 prior treatment lines.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e279, doi. 10.1016/j.clml.2019.09.460
- By:
- Publication type:
- Article
Increased Mutational Burden and Alterations to DNA Damage Repair Genes are Associated With Poor Prognosis and Sensitivity to PI3K-mTOR Inhibitors in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e2, doi. 10.1016/j.clml.2017.03.004
- By:
- Publication type:
- Article
Impact of plerixafor use in the mobilization of blood grafts for autologous hematopoietic cell transplantation.
- Published in:
- Transfusion, 2024, v. 64, n. 4, p. 742, doi. 10.1111/trf.17755
- By:
- Publication type:
- Article
Comparison of CD34<sup>+</sup> cell mobilization, blood graft cellular composition, and post‐transplant outcome in myeloma patients mobilized with filgrastim or pegfilgrastim added to low‐dose cyclophosphamide: A prospective multicenter study.
- Published in:
- Transfusion, 2021, v. 61, n. 11, p. 3202, doi. 10.1111/trf.16645
- By:
- Publication type:
- Article
Autograft cellular composition and outcome in myeloma patients: Results of the prospective multicenter GOA study.
- Published in:
- Transfusion, 2021, v. 61, n. 6, p. 1830, doi. 10.1111/trf.16424
- By:
- Publication type:
- Article
Mobilization characteristics, blood graft composition, and outcome in diffuse large B‐cell lymphoma after autologous stem cell transplantation: Results from the prospective multicenter GOA study.
- Published in:
- Transfusion, 2021, v. 61, n. 2, p. 516, doi. 10.1111/trf.16198
- By:
- Publication type:
- Article
Impact of lenalidomide-based induction therapy on the mobilization of CD34<sup>+</sup> cells, blood graft cellular composition, and post-transplant recovery in myeloma patients: a prospective multicenter study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Blood graft cellular composition and posttransplant outcomes in myeloma patients mobilized with or without low-dose cyclophosphamide: a randomized comparison.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non-Hodgkin's lymphoma patients.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non- Hodgkin's lymphoma patients.
- Published in:
- Transfusion, 2014, v. 54, n. 5, p. 1243, doi. 10.1111/trf.12434
- By:
- Publication type:
- Article
CD34+ cell subclasses and lymphocyte subsets in blood grafts collected after various mobilization methods in myeloma patients.
- Published in:
- Transfusion, 2013, v. 53, n. 5, p. 1024, doi. 10.1111/j.1537-2995.2012.03848.x
- By:
- Publication type:
- Article
Blood graft lymphocyte subsets after plerixafor injection in non-Hodgkin's lymphoma patients mobilizing poorly with chemotherapy plus granulocyte-colony-stimulating factor.
- Published in:
- Transfusion, 2012, v. 52, n. 8, p. 1785, doi. 10.1111/j.1537-2995.2011.03525.x
- By:
- Publication type:
- Article
Preemptive use of plerixafor in difficult-to-mobilize patients: an emerging concept.
- Published in:
- Transfusion, 2012, v. 52, n. 4, p. 906, doi. 10.1111/j.1537-2995.2011.03349.x
- By:
- Publication type:
- Article
Late potentials and QT dispersion after high-dose chemotherapy in patients with non-Hodgkin lymphoma.
- Published in:
- Clinical Physiology & Functional Imaging, 2010, v. 30, n. 3, p. 175, doi. 10.1111/j.1475-097X.2009.00920.x
- By:
- Publication type:
- Article
Bisphosphonate Therapy in Multiple Myeloma.
- Published in:
- Acta Oncologica, 1996, v. 35, n. S5, p. 55, doi. 10.3109/02841869609083969
- By:
- Publication type:
- Article
Serum caspase-cleaved cytokeratin-18 fragment as a prognostic biomarker in hematological patients with febrile neutropenia.
- Published in:
- Clinical & Experimental Medicine, 2022, v. 22, n. 1, p. 83, doi. 10.1007/s10238-021-00734-8
- By:
- Publication type:
- Article
Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia.
- Published in:
- Disease Markers, 2017, p. 1, doi. 10.1155/2017/9805609
- By:
- Publication type:
- Article
A minor role of asparaginase in predisposing to cerebral venous thromboses in adult acute lymphoblastic leukemia patients.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 6, p. 1275, doi. 10.1002/cam4.1094
- By:
- Publication type:
- Article
Incidence of solid cancer in patients with follicular lymphoma.
- Published in:
- Acta Oncologica, 2019, v. 58, n. 11, p. 1564, doi. 10.1080/0284186X.2019.1643918
- By:
- Publication type:
- Article
Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study.
- Published in:
- Acta Oncologica, 2015, v. 54, n. 6, p. 939, doi. 10.3109/0284186X.2014.990110
- By:
- Publication type:
- Article
Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 5, p. 492, doi. 10.1111/ejh.12626
- By:
- Publication type:
- Article
Cell cycle regulation score predicts relapse-free survival in non-germinal centre diffuse large B-cell lymphoma patients treated by means of immunochemotherapy.
- Published in:
- European Journal of Haematology, 2013, v. 91, n. 1, p. 29, doi. 10.1111/ejh.12117
- By:
- Publication type:
- Article
Blood graft composition after plerixafor injection in patients with NHL.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 2, p. 128, doi. 10.1111/j.1600-0609.2012.01794.x
- By:
- Publication type:
- Article
Pentraxin 3 predicts complicated course of febrile neutropenia in haematological patients, but the decision level depends on the underlying malignancy.
- Published in:
- European Journal of Haematology, 2011, v. 87, n. 5, p. 441, doi. 10.1111/j.1600-0609.2011.01666.x
- By:
- Publication type:
- Article
Efficacy of pre-emptively used plerixafor in patients mobilizing poorly after chemomobilization: a single centre experience.
- Published in:
- European Journal of Haematology, 2011, v. 86, n. 4, p. 299, doi. 10.1111/j.1600-0609.2010.01573.x
- By:
- Publication type:
- Article
Mobilization strategies in hard-to-mobilize patients with lymphoid malignancies.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 6, p. 463, doi. 10.1111/j.1600-0609.2010.01520.x
- By:
- Publication type:
- Article
Serum vascular endothelial growth factor in adult haematological patients with neutropenic fever: a comparison with C-reactive protein.
- Published in:
- European Journal of Haematology, 2009, v. 83, n. 3, p. 251, doi. 10.1111/j.1600-0609.2009.01260.x
- By:
- Publication type:
- Article
Blood stem cell mobilization and collection in patients with lymphoproliferative diseases: practical issues.
- Published in:
- European Journal of Haematology, 2008, v. 80, n. 4, p. 287, doi. 10.1111/j.1600-0609.2007.01026.x
- By:
- Publication type:
- Article
Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group.
- Published in:
- European Journal of Haematology, 2007, v. 78, n. 6, p. 477, doi. 10.1111/j.1600-0609.2007.00846.x
- By:
- Publication type:
- Article
Bisphosphonate therapy in multiple myeloma: past, present, future.
- Published in:
- European Journal of Haematology, 2002, v. 69, n. 5/6, p. 257, doi. 10.1034/j.1600-0609.2002.02796.x
- By:
- Publication type:
- Article
Inherited giant platelet disorders.
- Published in:
- European Journal of Haematology, 1994, v. 53, n. 4, p. 191, doi. 10.1111/j.1600-0609.1994.tb00187.x
- By:
- Publication type:
- Article
Mortality among patients with low‐grade follicular lymphoma: A binational retrospective analysis.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 13, p. 2474, doi. 10.1002/cncr.34221
- By:
- Publication type:
- Article
Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 1, p. 64, doi. 10.1111/bjh.18597
- By:
- Publication type:
- Article
Link between disease status at 24 months and mortality in follicular lymphoma.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 3, p. 458, doi. 10.1111/bjh.18423
- By:
- Publication type:
- Article
Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 3, p. 364, doi. 10.1111/bjh.16090
- By:
- Publication type:
- Article
Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma.
- Published in:
- Carcinogenesis, 2017, v. 38, n. 8, p. 812, doi. 10.1093/carcin/bgx061
- By:
- Publication type:
- Article
Novel Biomarker Candidates for Febrile Neutropenia in Hematological Patients Using Nontargeted Metabolomics.
- Published in:
- Disease Markers, 2018, p. 1, doi. 10.1155/2018/6964529
- By:
- Publication type:
- Article